Due to the persistent lack of suitable vaccines, chemotherapy remains the only option for the treatment of patients infected by protozoan parasites. However, most available antiparasitic drugs have serious disadvantages, ranging from high cost and poor compliance to high toxicity and rapid induction of resistance. In recent decades basic research laboratories identified a considerable number of promising new molecules, but their development has not been pursued in depth by pharmaceutical firms because of poor prospects of economic return. The establishment of adequately funded public-private partnerships is currently reversing the trend. This review deals with new drugs against Plasmodium, Leishmania and Trypanosoma parasites, focusing on the molecules that are in the most advanced stage of development. The purpose of this article is to provide the reader with a panoramic view of the updated literature on the challenges and strategies of contemporary antiprotozoal drug research, paying the due attention to the already published reviews.

New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases.

ZUCCA, Mario;SCUTERA, SARA AGATA CATERINA;SAVOIA, Dianella
2013

Abstract

Due to the persistent lack of suitable vaccines, chemotherapy remains the only option for the treatment of patients infected by protozoan parasites. However, most available antiparasitic drugs have serious disadvantages, ranging from high cost and poor compliance to high toxicity and rapid induction of resistance. In recent decades basic research laboratories identified a considerable number of promising new molecules, but their development has not been pursued in depth by pharmaceutical firms because of poor prospects of economic return. The establishment of adequately funded public-private partnerships is currently reversing the trend. This review deals with new drugs against Plasmodium, Leishmania and Trypanosoma parasites, focusing on the molecules that are in the most advanced stage of development. The purpose of this article is to provide the reader with a panoramic view of the updated literature on the challenges and strategies of contemporary antiprotozoal drug research, paying the due attention to the already published reviews.
20
4
502
526
http://www.eurekaselect.com/106519/article
malaria; leishmaniosi; tripanosomiasi; chemioterapia
Zucca M; Scutera S; Savoia D.
File in questo prodotto:
File Dimensione Formato  
Zucca M 2013 CMC post print.pdf

Accesso aperto con embargo fino al 28/02/2014

Descrizione: Articolo prinicipale
Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 734.47 kB
Formato Adobe PDF
734.47 kB Adobe PDF Visualizza/Apri
Curr Med Chem Zucca 2013.pdf

Accesso riservato

Descrizione: Articolo prinicipale
Tipo di file: PDF EDITORIALE
Dimensione 9.45 MB
Formato Adobe PDF
9.45 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2318/127169
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 27
  • ???jsp.display-item.citation.isi??? 27
social impact